Fact CheckerSign in

NCT06028152Completed

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning

Adapting an Advance Care Planning Intervention and Delivery Model for Use With Patients With Cancer and Their Caregivers

Source: ClinicalTrials.gov · Last updated 28 Feb 2024

Brief summary (registry, in English)

The goal of this clinical trial is to explore feasibility, acceptability, and effectiveness of end-of-life conversation game "Hello" as a tool to help individuals with breast, lung, and/or genito-urinary cancers treated at Penn State Cancer Institute and their loved ones perform advance care planning. The main questions it aims to answer are: * What modifications and/or adaptations are necessary to Hello for use in cancer populations? * How do different delivery models compare for recruitment in terms of feasibility and efficiency? Participants will: * Complete pre-game questionnaires * Play the Hello game * Complete post-game questionnaires * Participate in a focus group

Status (registry)
Completed
Study type
Interventional
Enrollment
14 (actual)
First submitted
29 Aug 2023
Start date
31 Oct 2023
Primary completion date
31 Jan 2024
Lead sponsor
Milton S. Hershey Medical Center
Diseases
Lung cancer
NCT number
NCT06028152

What you commit to

  • Study type: Interventional
  • Participants enrolled: 14
  • From 31 Oct 2023 to the primary completion date, 31 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Receives cancer care exclusively outside of Penn State Health

Age

  • Anyone \<18 years of age
  • Anyone \<18 years of age

Other

  • Anyone unable to speak and read English
  • Unable to provide informed consent
  • Anyone unable to speak and read English
  • Unable to provide informed consent

Who the study is looking for

  • Adults (\> 18 years old)
  • Able to speak and read English
  • Be an individual diagnosed with breast, lung, or genitourinary/prostate cancer as verified by primary oncologist or is the chosen caregiver for a participant with those cancers
  • Receives care at Penn State Health or is the chosen caregiver for a participant treated at Penn State Health
  • Adults (\> 18 years old)
  • Able to speak and read English and/or Spanish
  • Be the chosen caregiver for a participant with cancer

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Penn State Cancer Institute
Coordinator of this site? Confirm its status
HersheyUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.